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Executive Summary 
BACKGROUND 
In Kenya, the maternal mortality ratio remains high at 488 deaths per 100,000 live births with 35 per cent of 
these deaths arising from unsafe abortion. Public debate on abortion and on proposals to liberalize the abortion 
law has been on-going for several years in the country. With the passing of a new Constitution in 2010, there 
was renewed interest in the right to health and the need to reduce the high levels of maternal morbidity and 
mortality arising from unsafe abortion in the country. In 2012, for instance, the Government issued Standards 
and Guidelines for Reducing Morbidity and Maternal from Unsafe Abortion that emphasized professional non-
judgmental counseling and provision of safe options in cases of unplanned, risky or unwanted pregnancies in 
line with the Constitution. The Constitution, on the other hand, stipulates that abortion is permissible if in the 
opinion of a trained health professional, there is need for emergency treatment, or the life or health of the mother 
is in danger or as determined by any other law. Apart from the legal and policy discourses, medical abortion using 
a combination treatment of Mifepristone and Misoprostol has been classified by WHO as a safe and effective 
method to stop a pregnancy up to 9 completed weeks since the last menstrual period i.e. during the first 
trimester. The two drugs are registered in Kenya for various indications, including treatment of 
incomplete abortion and miscarriage, treatment and prevention of post-partum haemorrhage (PPH), 
treatment of intrauterine foetal death, cervical ripening, and as a uterotonic drug to induce or increase 
uterine contractions. In spite of the developments, there is limited understanding of the extent to which the 
changes have influenced the provision of medical abortion information and services in the country, the 
acceptability of the practice among providers and clients, and the content of care offered. 
OBJECTIVES 
The overall goal of the study was to generate evidence on the availability, use and quality of care for medical 
abortion services in private facilities (pharmacies and clinics) in Kenya. The specific objectives of the study were 
to: (1) understand the contextual and programmatic factors that influence or are likely to influence the provision 
of medical abortion services in Kenya; (2) explore the perspectives (positive and negative) of various 
stakeholders about abortion generally and the provision of medical abortion services specifically; (3) assess the 
availability of Mifepristone and Misoprostol or other abortifacient as well as the skills and practices of private 
providers; (4) examine the knowledge and attitudes of private providers regarding Mifepristone and Misoprostol 
or other abortifacients; (5) determine the characteristics, choices and perceptions of clients seeking abortion 
services from private clinics; and (6) explore the information and services given to clients seeking medical 
abortion services from private pharmacies and clinics. Private facilities were targeted because access to 
information and services on medical abortion in Kenya is mainly through private practitioners while public health 
facilities mostly provide post-abortion care services. Private clinics are operated by the cadres of providers that 
fall within the legal definition of a health professional including doctors, clinical officers, nurses and midwives 
while registered pharmacists and enrolled pharmaceutical technologists are the only cadres of health personnel 
qualified to dispense medicines and operate private pharmacies in the country. 
METHODS 
This was a cross-sectional study that was conducted between April and June 2013 in Nairobi, Kisumu and 
Mombasa counties. The study involved: (1) key informant interviews with 19 senior managers from national and 
locally-based international institutions representing policy, program, research and donor interests in 
reproductive health in general and medical abortion in particular; (2) structured interviews with 235 pharmacy 
workers in 235 private pharmacies; (3) 401 simulated client visits to 142 private pharmacies whose workers 
participated in the structured interviews; (4) structured interviews with 45 in-charges of private clinics; (5) 141 
observations of client-provider interactions during consultations in 32 of the 45 private clinics; and (6) 125 exit 
interviews with clients seeking abortion services in the 32 private clinics. The interviews with key informants 
were transcribed, typed in Word and analysed for content using NVIVO software. Analysis involved coding of 
themes and categorizing the themes within a hierarchical framework of main and sub-themes. Quantitative data 
from structured interviews with pharmacy workers, simulated client visits to pharmacies, structured interviews 
with facility in-charges, observations of client-provider interactions, and exit interviews with clients were entered 
in EpiData and analysed using STATA. Analysis involved simple descriptive statistics including percentages, 
means and medians. 
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KEY FINDINGS 
Abortion Environment: Perspectives of Key Informants 
 
 Although there has been progress in the legal and policy frameworks regarding abortion to increase the 
availability of safe and legal services, many service delivery challenges still persist. Limited dissemination of 
relevant documents and lack of clear and officially endorsed policy statements to guide public health 
facilities mean that there is a lack of awareness about the revised service standards and guidelines among 
service providers and the conditions under which safe abortion services can be legally provided. 
 
 Although several non-governmental organizations and professional associations have developed curricula 
and supported training of service providers, especially from the private sector, on comprehensive abortion 
care, values clarification and attitude transformation and referrals, there is no standard training curriculum 
while skills gaps still persist among providers. 
 
 Effective delivery of safe legal abortion services are further affected by societal stigma, poor access to 
appropriate information especially among those from marginalised settings, inadequate supply of drugs due 
to few established distribution channels, poor packaging and storage of relevant drugs, availability of 
counterfeits, and price distortion brought about by some of these challenges. 
 
Abortion Services in Private Pharmacies 
 
 Very few pharmacy workers (16%) whose outlets provided abortion information or methods had been trained 
on the provision of the services with trainings focusing more on ensuring confidentiality and privacy of 
clients, history taking, and pain management, and less on the national standards and guidelines, record-
keeping and reporting, criteria for referral procedures and the recommended regimens for the combination 
of Mifepristone and Misoprostol. 
 
 There was limited stocking of Misoprostol or Mifepristone even in pharmacies that provided abortion 
information or methods with only 18% of such pharmacies selling Misoprostol, 2% sold Mifepristone while 
none sold the combination of Mifepristone and Misoprostol. In addition, most of the pharmacies did not 
have the national standards and guidelines document on reducing maternal mortality and morbidity from 
unsafe abortion. 
 
 There was limited knowledge of the correct regimen for Misoprostol only (22% of males and 16% of females) 
or for combination of Mifepristone and Misoprostol (13% of males and 3% of females) for pregnancies of 
various gestational ages among pharmacy workers who knew about the medications. 
 
 Although nearly all pharmacy workers (97%) felt that clients seeking Mifepristone and Misoprostol from 
pharmacies should have a prescription from a medical practitioner, only 11% indicated having ever denied 
clients abortion services because of lack of a prescription while the most common reasons for denial of 
services were religious or moral beliefs or lack of a trained provider. 
 
 Pharmacy workers performed poorly on all indicators of interactions with simulated clients although the 
chances of asking about gestational age (55% of interactions) and advising clients on where to obtain 
services for pregnancy termination (50% of interactions) were higher than those of discussing family 
planning (12% of interactions), recommending family planning (9% of interactions), offering a method (1% 
of interactions), or referring clients elsewhere for family planning (1% of interactions). 
 
Abortion Services in Private Clinics 
 
 The most common aspects related to the provision of abortion services that private providers had received 
in-service training on were infection prevention (78% of facilities), referral procedures (76% of facilities); and 
managing complications (76% of facilities) while the least aspects were the national standards and 
guidelines (60% of facilities) and the legal and policy provisions regarding abortion (51% of facilities). 
 
 Availability of drugs and supplies for medical abortion was very limited (15% of items) although the 
proportion of items that were in stock on the day of interview was similar to what were reported to be 
available. By contrast, facilities had most of the drugs and supplies for surgical abortion (81% of items) as 
well as for recovery, pain management and treatment of complications (85% of items) although the 
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proportions of items that were in stock on the day of interview were lower than what was reported to be 
available. 
 
 Although providers mostly cited health reasons (64% of providers) and preservation of the mother’s life (43% 
of providers) as the common legal grounds for induced abortion, about a quarter (23%) noted that induced 
abortion can be provided on request, which is contrary to existing laws and regulations. In addition, only 
about half (49%) of providers whose facilities stocked Misoprostol mentioned the correct regimen for 
pregnancies of various gestational ages. 
 
 Two-thirds (66%) of the women seeking abortion services from private clinics were aged between 20 and 29 
years, 64% had at least secondary level education, 59% were never married while 56% had a previous 
pregnancy, with the majority of those who had more than one pregnancy (86%) reporting having a previous 
abortion. 
 
 More than half (59%) of clients seeking abortion services had pregnancies of up to 9 weeks with the most 
common reason for seeking abortion services being that the pregnancy was unplanned (73%) while other 
reasons included the need to continue with education (24%), family pressure (14%), and the need to 
continue with employment (14%). 
 
 Providers recommended the correct regimen for gestational age in only 31% of consultations in which 
medical abortion (Misoprostol alone or combination of Mifepristone and Misoprostol) was recommended. 
By contrast, providers recommended manual vacuum aspiration for 54% of pregnancies of up to 9 weeks, 
59% of pregnancies above 9 and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% 
of pregnancies over 14 weeks. 
 
 Although nearly all (98%) private clinics reported providing family planning information or methods, only 79% 
of the clients seeking abortion services were counselled on family planning while 48% were given a method. 
Besides, elements of family planning counselling were some of the least performed functions during 
consultations (40% of elements performed) while elements of interpersonal relationships such as courteous 
handling of clients were some of the most performed by providers (74% of elements performed). 
 
 The majority of clients seeking abortion services (78%) had previously used a family planning method, mostly 
male condom, oral pills, injectables, and emergency pill. Nearly two-thirds (63%) chose a method on the day 
of visit, mostly injectables (40%), male condoms (33%), pills (20%), implants (18%), and IUCDs (18%) while 
60% of those who had a previously used a method chose a different method, mostly injectables, IUCD and 
implants. 
 
 Prices of medical abortion drugs increased with higher gestation age of pregnancy although there were wide 
variations in the prices facilities charge for the methods, ranging from KSh. 90 (≈US $1) to KSh. 7,000 (≈US 
$82). Prices of surgical abortion methods also varied widely between facilities from KSh. 1,500 (≈US $18) 
to KSh. 15,000 (≈US $176). 
IMPLICATIONS 
 There is need for widespread and government-endorsed dissemination of the revised laws, policies, 
standards and guidelines on abortion services among health care providers for improved clarity regarding 
the provision of safe legal abortion services. 
 
 There is need for a standard approach to improving the capacity of private providers to offer safe abortion 
services including having a standard training curriculum, which incorporates counselling on proper use of 
medication, family planning (especially long-term methods) and referrals for clients seeking abortion 
services. 
 
 There is need to address some of the barriers to delivery and uptake of safe legal abortion services such as 
stigma and lack of access to information through public awareness especially regarding existing laws and 
policies on abortion and available services. 
 
 There is need to ensure proper packaging of medical abortion products and to address the issue of 
counterfeits, for instance, by designing unique moisture-proof packages with bar codes that would be 
difficult to imitate to reduce the chances of users getting substandard products which can compromise their 
health.  
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 There need to improve the supply chain to reduce stock-outs of essential drugs (especially combined 
Mifepristone and Misoprostol) in private pharmacies and clinics that provide abortion information or 
methods. 
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Background 
 
The World Health Organization (WHO) estimates that globally, approximately 210 million pregnancies occur 
each year with over 135 million resulting in live-born infants while the remaining 75 million end in stillbirth 
or (spontaneous or induced) abortion (WHO 2011). Available estimates further show that there were 213 
million pregnancies worldwide in 2012 with 85 million (40 per cent) of them being unintended and half of 
the unintended pregnancies resulting in abortion (Sedgh et al. 2014). Most of the abortions are considered 
unsafe i.e. they are performed by untrained practitioners or provided in unhygienic settings (Singh et al. 
2009; WHO 2004). Unsafe abortion accounts for 13 per cent (47,000) of global maternal deaths worldwide 
while about 60 per cent of abortion-related deaths take place in Africa (Shah and Åhman 2010; United 
Nations 2010).  
 
Globally, WHO estimated that there were 21.6 million unsafe abortions worldwide in 2008 with Africa having 
the second highest rate of unsafe abortion (28 per 1,000 women aged 15-44 years) after Latin America and 
the Caribbean which had a rate of 35 (WHO 2011). The rate of unsafe abortions was also higher in regions 
with restrictive compared to those with less restrictive abortion laws (WHO 2011). Studies show that although 
abortion is restricted in many countries in sub-Saharan Africa except for circumstances when the pregnancy 
endangers the life of the mother, abortion-related complications account for the majority of admissions to 
gynecological wards of hospitals in the region (Levandowski et al. 2012, 2013; Singh et al. 2005).  
 
In Kenya, the maternal mortality ratio remains high at 488 deaths per 100,000 live births with 35 per cent 
of these deaths arising from unsafe abortion (Centre for Reproductive Rights 2010; Kenya National Bureau 
of Statistics [KNBS] and ICF Macro 2010; Ministry of Health 2003). A 2013 study that used patient-specific 
data for women who sought abortion-related care at health facilities found that the rate of induced abortions 
in the country was 48 per 1,000 women aged 15-49 years in 2012, higher than the 2002 rate of 45 per 
1,000 women (Republic of Kenya 2013). The study further found that 37 per cent of the women seeking 
post-abortion care services had severe complications such as high fever, sepsis, shock and organ failure, 
indicating that abortion might have occurred under unsafe conditions (Republic of Kenya 2013).  
 
Public debate on abortion and on proposals to liberalize the abortion law has been on-going for several years 
in Kenya (Brookman-Amissah and Moyo 2004). With the passing of a new Constitution in 2010, there was 
renewed interest in the right to health and the need to reduce the high levels of maternal morbidity and 
mortality arising from unsafe abortion in the country (Republic of Kenya 2010a; 2012). In 2012, for instance, 
the Government issued Standards and Guidelines for Reducing Morbidity and Maternal from Unsafe 
Abortion that emphasized professional non-judgmental counseling and provision of safe options in cases of 
unplanned, risky or unwanted pregnancies in line with the Constitution (Republic of Kenya 2012). The 
Constitution, on the other hand, stipulates that abortion is permissible if in the opinion of a trained health 
professional, there is need for emergency treatment, or the life or health of the mother is in danger or as 
determined by any other law (Republic of Kenya 2010a). Furthermore, Article 43(1)(a) of the Constitution 
states that every person has the right to the highest attainable standard of health, which includes the right 
to health care services, including reproductive health care (Republic of Kenya 2010a). 
 
Apart from the legal and policy discourses, medical abortion using a combination treatment of Mifepristone 
and Misoprostol has been classified by WHO as a safe and effective method to stop a pregnancy up to 9 
completed weeks since the last menstrual period i.e. during the first trimester (WHO 2012). Misoprostol is 
registered in Kenya as a multi-purpose drug whose indications include duodenal ulcer, gastric ulcer, 
treatment of incomplete abortion and miscarriage, treatment and prevention of post-partum haemorrhage 
(PPH), treatment of intrauterine fatal death and cervical ripening. Mifepristone is also registered as a 
medication indicated for duodenal ulcer, gastric ulcer, cervical ripening and as a uterotonic drug to induce 
or increase uterine contractions. The availability of these two drugs in the country could replace surgical and 
non-surgical invasive methods that have previously been used to terminate pregnancies, both illegally and 
legally (Ong’ech et al. 2008). 
 
In spite of the developments, there is limited understanding of the extent to which the changes have 
influenced the provision of medical abortion information and services in the country, the acceptability of the 
practice among providers and clients, and the content of care offered. This report presents findings from a 
study whose aim was to generate evidence on the current knowledge about medical abortion, availability of 
the services, as well as the nature of information exchange between clients and private providers (clinics 
and pharmacies). The study was conducted in three counties, namely, Nairobi, Kisumu, and Mombasa 
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between April and June 2013. The counties were purposively selected based on availability of private clinics 
that were likely to provide medical abortion drugs. Private providers were targeted because access to 
information and services on medical abortion in Kenya is mainly through private practitioners while public 
health facilities mostly provide post-abortion care services (Wamugi et al. 2014). In addition, the counties 
have varied levels of reproductive health indicators such as contraceptive use (63% in Nairobi, 62% in 
Kisumu and 55% in Mombasa) and fertility (2.7 children per woman in Nairobi, 3.6 in Kisumu and 3.2 in 
Mombasa; KNBS et al. 2014). 
 
The subsequent sections of this report are divided into three major parts based on the key institutions that 
were included in the study, namely, organizations with interest in reproductive health, private pharmacies, 
and private clinics. Each part provides a brief introduction including the objectives of gathering information 
from the institutions, methods, key findings and implications of the findings. The study obtained ethical 
approval and research clearance from the Institutional Review Board of the Population Council, the Ethics 
Review Committee of Kenya Medical Research Institute (KEMRI), the National Council for Science and 
Technology (NCST), and Marie Stopes International Ethical Review Committee. Written informed consent was 
obtained from all participants before data collection. 
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Abortion Environment in Kenya: 
Perspectives of Key Informants  
 
INTRODUCTION 
 
Institutions working in the field of reproductive health can contribute to improved client outcomes through 
policy formulation, advocacy, program implementation, research to generate evidence to inform policy and 
programming, as well as funding of programs. With respect to abortion in Kenya, some of the institutions 
that have been at the forefront of promoting public debate on the issue since 2004 include an alliance 
formed by the Kenya Medical Association (KMA), the Kenya Obstetrics and Gynaecology Society (KOGS), the 
Federation of Women Lawyers and Ipas (Brookman-Amissah and Moyo 2004). The 2010 Constitution 
generated further debate on the issue especially regarding the meaning of reproductive health, trained 
health professional, or the phrase “as determined by any other law”. For instance, the Constitution does not 
provide a definition of health or reproductive health but according to the 1994 International Conference on 
Population and Development (ICPD), reproductive health is a state of complete physical, mental and social 
well-being and not merely the absence of disease or infirmity in all matters relating to the reproductive 
system and to its functions and processes (United Nations 1994). Since Kenya was a signatory to the 1994 
ICPD, the right to reproductive health care as enshrined in the Constitution can therefore be interpreted to 
include safe legal abortion, which is an important component of reproductive health services within a country 
(WHO 2004). 
 
Apart from advocacy, other private sector institutions have focused on providing safe legal medical and 
surgical abortion services to clients. The Reproductive Health Network (RHN), for instance, is a network of 
public and private sector service providers committed to reducing maternal morbidity and mortality 
associated with unsafe abortion (Reproductive Health Network 2015). The Kenyan Chapter of Africa Network 
for Medical Abortion (ANMA) brings together private sector providers providing medical abortion. The 
institutions have also strengthened the referral systems by creating networks of gynaecologists, clinical 
officers, nurses and midwives. Informed by the Ministry of Health’s (MOH) community strategy (Ministry of 
Health 2006), the institutions have engaged community health workers to identify and refer clients with a 
view to increasing access to safe abortion services in order to reduce maternal morbidity and mortality arising 
from unsafe abortions. There are also various community initiatives to increase access to reproductive health 
services. For example, the Male Involvement in Safe Abortion (MISA) project run by Kisumu Medical and 
Education Trust (KMET) in Kisumu trains men to be reproductive health champions in the community and to 
make referrals (KMET 2014). KMET also implements Sisterhood for Change project which trains teenage 
mothers in life skills and to advocate for their rights to enable them act as change agents in their 
communities (KMET 2014). 
 
Other institutions have focused on enhancing the capacity of providers to address unsafe abortion through 
in-service training. Trainings have focused on comprehensive abortion care (including medical and surgical 
abortions) to improve the safety of abortion services, and on values clarification and attitude transformation 
(VCAT) to address the negative attitudes and beliefs about abortion. Organizations such as ANMA, 
Reproductive Health and Rights Alliance (RHRA), RHN and KOGS have been at the forefront in the 
development of training curricula and training of service providers. The cadres of providers trained are those 
that fall within the legal definition of a health professional including doctors, clinical officers, nurses and 
midwives. Most training has been for middle level providers (clinical officers, nurses and midwives) since 
they are the majority from whom poor women seek care. Mid-level providers are mostly trained to conduct 
abortions up to 12 weeks gestation, while an abortion in the second trimester can only be performed by 
doctors and gynaecologists. Some organizations (such as ANMA) have also started training pharmacists on 
making the right decisions when women seek to buy Misoprostol over the counter and also to refer the clients 
to the nearest ANMA member (ANMA Kenya 2014).   
 
Based on the prevailing legal, policy and program environment regarding abortion, a key question is how the 
actors view the developments in the context of provision of quality care to clients. The prevailing environment 
may also determine whether the institutions allocate resources (human or financial) to influence policy and 
programs. The objectives of this component of the study were therefore: 
1) To understand the contextual and programmatic factors that influence or are likely to influence the 
provision of medical abortion services in Kenya; and 
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2) To explore the perspectives (positive and negative) of various stakeholders about abortion generally 
and the provision of medical abortion services specifically. 
 
METHODOLOGY 
 
A total of 19 key informant interviews were conducted with the senior managers from national and locally-
based international institutions with interest in reproductive health in general and medical abortion in 
particular. The institutions were purposively selected to represent policy, program, research and donor 
interests. The institutions comprised the Ministry of  Health, KOGS, the National Nurses Association of Kenya 
(NNAK), the Kenya Clinical Officers Association (KCOA), the University of Nairobi Department of Obstetrics 
and Gynaecology, Marie Stopes Kenya (MSK), Family Health Options Kenya (FHOK), the Kenya Chapter of 
the Africa Network for Medical Abortion (ANMA), the Reproductive Health Network  (RHN), Reproductive 
Health and Rights Alliance (RHRA), Ipas, Woman Care Global, the International Planned Parenthood 
Federation (IPPF), Kenyatta National Hospital (KNH) and KMET. Each institution identified one senior 
manager who provided information on the state of medical abortion services in Kenya.  
 
Key informants were persons aged 18 years and above. The interviews were conducted in English and were 
tape-recorded with the consent of the informants. The interviews were transcribed, typed in Word and 
analysed for content using NVIVO software. Analysis involved coding of themes and categorizing the themes 
within a hierarchical framework of main and sub-themes. The thematic framework was used to compare and 
contrast patterns of the themes between different key informants. The data from the interviews provide 
contextual information on the status of medical abortion in Kenya. 
 
FINDINGS 
 
Key informants reported that since the enactment of the 2010 Constitution, the abortion environment has 
been changing rapidly especially with respect to the legal and policy frameworks, training of service 
providers, service delivery, and availability of abortion commodities (equipment and drugs) although 
challenges remain. 
 
Legal and Policy Frameworks 
 
Key informants noted that there have been some developments in the legal and policy frameworks regarding 
abortion in Kenya. For instance, all key informants felt that the Standards and Guidelines for Reducing 
Morbidity and Mortality from Unsafe Abortion in Kenya was a good reference material that offered clear 
guidance for health workers who offer abortion services, as well as clarifying situations in which the health 
worker might not be willing to provide services due to personal beliefs.  As one key informant noted: 
 
So far I think it’s [the Standards and Guidelines] a good one. I think its good enough to start off with. We 
can improve. It is giving the women and the service providers all the options. If you have an unwanted 
pregnancy, it gives you the option to adoption. The last part of it takes care of all the providers. The last one 
was only the doctors or a psychiatrist. If the providers are educated on it well, they can understand it well. 
I feel it’s a good one. We now have a reference material. 
 
Despite availability of the standards and guidelines document, key informants noted that it is yet to be 
disseminated widely, which has in turn affected its full implementation. MOH representatives stated that 
dissemination has been hampered by lack of adequate funds. In addition, the MOH has not issued a policy 
statement (through a circular or otherwise) that can be followed by public health facilities. These policy gaps 
have sometimes been exploited by the police to harass health workers known to provide abortion services 
legally. Key informants reported that: 
 
Very few people even at our level know what the guidelines say. It was just last week we were planning to do 
a survey in [name of facility] to look at the efficacy and efficiency of the two tier levels on the use of Misoprostol 
and post-abortion care. When we applied for approval from the hospital ethical committee, the first comment 
they gave us was by asking who gave midwives the authority to offer post-abortion care. So I had to come 
back to the office and carry a hard copy. The issue is that people are not aware, there are documents and so 
we need to disseminate. 
 
The legislation/policy needs to be very clear, and then we need to sensitize the health workers across the 
board for them to understand how the law protects them. It is a journey. But just saying the constitution has 
been passed and the standards and guidelines have been developed won’t work. 
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Training of Service Providers 
 
Key informants reported that in spite of the provider trainings that have been undertaken by various 
organizations, major skills and performance gaps in safe abortion services among health care providers 
remain. These include: 
 Poor knowledge of treatment protocols and drug dosages: This was largely because most health 
care providers have not read the protocols and drug specifications as outlined in the service 
standards and guidelines document. 
 Poor counselling skills: Apart from nurses, other cadres of health care providers lack adequate 
counselling skills, which were attributed to lack of pre-service training. 
 Poor surgical skills: Some doctors were reported to have the medical knowledge but lack practical 
skills for performing surgical abortion. 
 Lack of skills in patient assessment specific to abortion: Many providers have skills in general 
patient assessment, but lack skills specific to abortion including physical examination.   
 Poor skills in infection prevention and management of abortion complications: This is mostly among 
mid-level service providers (clinical officers, nurses and mid-wives). 
 Lack of service integration: This is particularly with respect to linking women to other services such 
as family planning. 
 
The informants reported that the skills and performance gaps could be addressed through well planned in-
service trainings on safe abortion in the short term but will require to be incorporated in the pre-service 
curriculum in the long term. They further noted that in-service trainings should follow a standard curriculum 
to ensure that there is a common approach to provision of safe abortion services as opposed to a situation 
where trainings are done using different curricula developed by different institutions as has been the case. 
 
Service Delivery 
 
Key informants reported that, ideally, it should be possible for a woman to receive safe and legal abortion 
services in public health facilities. However, the focus in the public sector is still on the management of post-
abortion complications. There is still reluctance and apprehension to provide medical abortion services 
mainly due to the lack of a clear policy statement on abortion in the public sector. Key informants further 
noted that besides the limited dissemination of the standards and guidelines, provision of safe abortion 
services in public health facilities is hindered by negative provider attitudes and beliefs. It was reported that 
some health care workers decline to offer services due to their religious beliefs (i.e. conscientious objection) 
or the widespread social stigma associated with abortion. A health care provider reported that: 
  
I do not mind what the Constitution says, my personal opinion is that we need to address. I think telling people 
the solution to irresponsible sexual behaviour is abortion [is wrong]. I think people are worried about 
pregnancy and not the consequences of unprotected sex, that is what we need to address. In emergency 
cases where there is rape and other cases, the services can be availed, but in situations where it is at will and 
in the era of HIV/AIDS, we need to be cautious. 
 
Informants identified various challenges/barriers to women’s ability to access safe medical abortion services 
to include: 
 Stigma: Both the women seeking the services and the providers offering the services are 
stigmatized, for example, being referred to as ‘baby killers’. Facilities identified to be offering safe 
abortion services are also stigmatized by the general public. 
 Inadequate number of trained health providers: Although progress has been made with in-service 
training of health workers, the numbers are still insufficient to meet demand. 
 Inadequate supply of drugs: Whereas Misoprostol and Mifepristone are registered, the distribution 
network is not yet well established. The drugs are readily available in major urban areas but scarce 
in small towns and rural areas. 
 Cost: The price of the drugs in areas where there is limited supply was also reported to be out of 
reach of poor women and the youth. For instance, while the actual cost of Misoprostol could be as 
low as KSh. 20, it was reported that in some places it could cost as high as KSh. 1,000. 
 Ignorance about the law: Many people are still not aware of the provisions of the Constitution 
regarding abortion services. Furthermore, others interpret the law narrowly in order to deny women 
services. 
 Limited number of facilities that provide safe abortion services: There are not many publicly known 
facilities that provide the services, while those that do are mostly found in urban areas and are 
mainly privately owned. In addition, lack of clear policy statement has acted as a barrier to the 
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provision of safe abortion services in public health facilities. 
 Quality of care: This is affected by the secretive nature of providing abortion services; hence clients 
may obtain counterfeit commodities from people operating unregistered facilities. Providers’ poor 
counselling skills as well as lack of awareness about service standards and guidelines also affect 
quality of care. 
 Poor access to information: Women in urban slums and rural areas and especially younger women 
lack information on where to get safe abortion services and/or advice. 
 
Availability of Supplies, Equipment and Drugs 
 
Informants noted that the registration of medical abortion drugs—Misoprostol and Mifepristone—represented 
major progress towards addressing unsafe abortions in Kenya. Misoprostol has also been included in the 
essential drug list which makes it possible for public health facilities to procure it. Various stakeholders, 
including drug companies, non-governmental organizations and networks of providers, now procure and 
distribute abortion drugs and equipment to private health facilities that are in need. However, informants 
identified a number of challenges affecting the supply chain (importation, storage, distribution and 
marketing) of medical abortion commodities. They noted that the challenges are severe at the 
supply/distribution stage, as evidenced by the pricing of medical abortion drugs. As one informant noted: 
 
As I said, the main challenge is the distribution outlets. If you are in [name of town], you need to go there and 
get the products at an affordable price. One time in [another town], I walked into a chemist and asked for 
Misoprostol, the lady told me I needed a prescription but I managed to convince her I was a health worker 
and she accepted. One tablet goes for KSh. 600 while a tablet here [name of facility] goes for KSh. 20, so you 
can imagine how many women are suffering. So the problem is at distribution and the cost. 
 
The specific challenges with the supply chain that informants identified included: 
 Importation bottlenecks: Similar to other medical products, challenges with importing medical 
abortion drugs and surgical abortion kits include paying for the products upfront, theft at customs, 
and delays in clearance by the customs authorities. These processes are time consuming and result 
in delays in getting the products to those who need them. 
 High price of products: The price of abortion products was noted to be generally high and this is 
occasioned by poor supply and distribution channels. There are very few companies and 
organizations involved in the procurement of abortion commodities. The limited distribution 
channels in the country pushes the prices of commodities beyond the reach of health facilities and 
clients. 
 Poor packaging and storage of drugs: Poor packaging of Misoprostol has been experienced, with 
some batches absorbing moisture, especially when poorly stored. 
 Availability of counterfeits: Counterfeits are available for Misoprostol and manual vacuum aspiration 
(MVA) kits especially in Nairobi. The supply of counterfeits compromises the provision of safe 
abortion services since quality cannot be guaranteed. Counterfeits also affect the pricing of 
commodities and legitimate providers are likely to lose out. 
 
SUMMARY AND IMPLICATIONS 
 
Summary of Findings 
 
 Although there has been progress in the legal and policy frameworks regarding abortion to increase the 
availability of safe and legal services, many service delivery challenges still persist. Limited 
dissemination of relevant documents and lack of clear and officially endorsed policy statements to guide 
public health facilities mean that there is a lack of awareness about the revised service standards and 
guidelines among service providers and the conditions under which safe abortion services can be legally 
provided. 
 
 Although several non-governmental organizations and professional associations have developed 
curricula and supported training of service providers, especially from the private sector, on 
comprehensive abortion care, values clarification and attitude transformation and referrals, there is no 
standard training curriculum while skills gaps still persist among providers. 
 
 Effective delivery of safe legal abortion services are further affected by societal stigma, poor access to 
appropriate information especially among those from marginalised settings, inadequate supply of drugs 
due to few established distribution channels, poor packaging and storage of relevant drugs, availability 
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of counterfeits, and price distortion brought about by some of these challenges.  
 
Implications 
 
 There is need for widespread and government-endorsed dissemination of the revised laws, policies, 
standards and guidelines on abortion services among health care providers for improved clarity 
regarding the provision of safe legal abortion services. 
 
 The finding that gaps still exist with respect to provider skills despite trainings conducted by different 
partners suggest the need for a standard approach to improving the capacity of providers to offer safe 
abortion services including having a standard training curriculum. 
 
 There is need to address some of the barriers to delivery and uptake of safe legal abortion services such 
as stigma and lack of access to information through public awareness especially regarding existing laws 
and policies on abortion and available services. 
 
 There is need to ensure proper packaging of medical abortion products and to address the issue of 
counterfeits, for instance, by designing unique moisture-proof packages with bar codes that would be 
difficult to imitate to reduce the chances of users getting substandard products which can compromise 
their health.  
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Abortion Services in Private 
Pharmacies  
 
INTRODUCTION 
 
Private pharmacies in Kenya play a critical role in ensuring access to essential medicines by those in need. 
The 2010 Kenya National Pharmaceutical Policy (KNPP) recognizes the right to access essential medicines 
especially by vulnerable population groups as part of the fundamental right to health as enshrined in the 
Constitution (Republic of Kenya 2010b). According to the policy, registered pharmacists and enrolled 
pharmaceutical technologists are the only cadres of health personnel qualified to dispense medicines and 
operate private pharmacies in the country (Republic of Kenya 2010b). However, private pharmacies face 
challenges that might affect the way consumers benefit from essential medicines. From a public health 
perspective, private pharmacies may lack the incentives to take up important steps in promoting rational 
decision-making by consumers including counselling on proper use of medicines or providing referrals for 
appropriate care. This could be attributed to the nature of training for pharmacists (which may not include 
the provision of public health information and services) and the fact that interactions with clients at private 
pharmacies are mostly with frontline staff some of whom lack formal training in health service provision 
(PATH 2004). Private pharmacy providers are further faced with the challenge of balancing operations as a 
business establishment and performing the role of health service providers (Skibiak et al. 2001; PATH 2004). 
 
The registration of Mifepristone and Misoprostol in Kenya made them part of the essential drugs list for 
distribution and sale through registered outlets including private pharmacies. The medications are 
distributed to registered private pharmacies and clinics by recognized distributors including Marie Stopes 
International for Misoprostol and Maxima Pharmaceuticals Limited for Mifepristone. The medications are 
registered for sale over the counter with prescriptions from a medical practitioner. Challenges associated 
with medicines being sold as commodities as well as those faced by private pharmacies may affect the way 
the two medications are sold to and used by consumers. There is, however, limited understanding of private 
pharmacy providers’ knowledge of the medications and existing regulations, how they dispense the 
medications and how they generally interact with clients seeking abortion services. The objectives of this 
component of the study were: 
1) To assess the availability of Mifepristone and Misoprostol or other abortifacient as well as the skills 
and practices of workers in private pharmacies; 
2) To examine the knowledge and attitudes of private pharmacy workers regarding Mifepristone and 
Misoprostol or other abortifacients; and 
3) To explore the information given to clients seeking medical abortion services at private pharmacies. 
 
METHODOLOGY 
 
This component of the study involved structured interviews with private pharmacy workers and simulated 
client visits to the pharmacies.  
 
Interviews with Pharmacy Workers  
 
In each county, 100 pharmacies were randomly sampled from the list of all registered private pharmacies. 
It is common for pharmacies and chains of pharmacies to be owned by one proprietor who employs workers 
to provide services to clients. For each sampled pharmacy, the owner was approached to provide written 
informed consent for his/her pharmacy to be included in the study. Of the 300 sampled pharmacies, owners 
of 274 granted consent (82 in Nairobi, 93 in Kisumu and 99 in Mombasa). Subsequently, trained research 
assistants visited these 274 pharmacies to conduct interviews with the pharmacy workers. One most senior 
pharmacy worker was interviewed in each pharmacy. To be eligible for interview, the pharmacy worker had 
to be actively involved in dispensing drugs, should have worked for at least six months at the pharmacy, and 
gave individual written informed consent. Interviews were completed with 235 pharmacy workers (82 in 
Nairobi, 80 in Kisumu and 73 in Mombasa), 36 refused (11 in Kisumu and 25 in Mombasa) while 3 
interviews were only partially completed (2 in Kisumu and 1 in Mombasa). 
  
The interviews aimed at determining the availability of medical abortion services as well as knowledge, 
attitudes and practices of the workers regarding the services. Information was captured on the background 
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characteristics of pharmacy workers (sex, age, education level and training), their knowledge of medical 
abortion products and regimens, service provision practices at the pharmacy, and the cost of Misoprostol 
and Mifepristone. Pharmacy workers were approximately equally male and female, with an average age of 
31 years (range of 22 to 58 years). Nearly all (97%) had secondary education and above. The majority (56%) 
worked at pharmacies in peri-urban areas, 34% were in pharmacies in the central business district of each 
urban centre, while 10% were in rural areas. The majority (80%) were employees and 92% reported that they 
were trained to dispense medicines. 
 
Simulated Client Visits 
 
The simulated client approach was used to understand service provision practices followed for clients 
seeking abortion services at pharmacies. Simulated clients were females aged between 18 and 31 years, 
and trained to assume one of the following four specific profiles of clients seeking medical abortion services 
from a pharmacy: 
 Scenario 1: A woman specifically wanting to purchase Misoprostol without stating a reason; 
 Scenario 2: A woman specifically wanting to purchase Misoprostol and stating that the reason is to 
end a pregnancy without stating the gestation period; 
 Scenario 3: A woman seeking any medication to end an 8-week pregnancy; and 
 Scenario 4: A woman seeking any medication to end a 12-week pregnancy (i.e. after the 
recommended threshold gestation). 
 
In each county, about half of the pharmacies whose workers were interviewed were visited by simulated 
clients. A total of 401 simulated client visits were made (136 in 53 pharmacies in Nairobi, 134 in 49 
pharmacies in Kisumu, and 131 in 40 pharmacies in Mombasa). Each pharmacy was visited an average of 
three times (minimum one, maximum 4) on different dates at least one week after the structured interviews 
with the pharmacy workers, over a period of one month. The minimum time period between visits was three 
days. No pharmacy was visited more than once by the same simulated client. Within one hour of each visit, 
the simulated client completed a structured questionnaire to record details of their interaction with the 
pharmacy workers including any information and product they were given. The visits were equally distributed 
among the four scenarios, i.e. 100 visits per scenario. 
 
Data Analysis 
 
Data from structured interviews with pharmacy workers and simulated client visits were entered in EpiData 
and analysed using STATA. Analysis involved simple descriptive statistics including percentages, means and 
medians. For simulated client data, Chi-square tests were performed to determine if differences between 
scenarios were statistically significant.   
 
RESULTS 
 
Staffing Levels and Staff Training 
 
The median number of staff at the pharmacies was 8 with a minimum of 1 and maximum of 8 persons. Only 
16% of the pharmacy workers who reported that their outlets provided abortion services (information or 
methods) had been trained on the provision of the services with wide variations between counties (52% in 
Nairobi, 15% in Kisumu and 2% in Mombasa). In addition, 10% of the pharmacy workers who reported that 
their outlets did not provide abortion services indicated that they had been trained to provide the services 
(12% in Nairobi, 11% in Kisumu and none in Mombasa). Pharmacy workers who indicated that they had been 
trained were asked to specify the aspects in which they had been trained (Figure 1). Most had been trained 
in ensuring confidentiality and privacy of clients (97%), history taking (91%), and pain management (88%), 
and relatively few had been trained in the national standards and guidelines (34%), record-keeping and 
reporting (38%) and criteria for referral procedures (38%).  
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Figure 1: Per cent distribution of pharmacy workers who had been trained on provision of abortion services by training 
specific aspects 
 
Notes: Multiple responses allowed; Number of cases=32. 
 
 
Misoprostol-only regimen was the most common method that pharmacy workers had been trained in, 
followed by MVA, dilatation and curettage, and dilatation and evacuation (Figure 2). Less than 10% of the 
trained pharmacy workers had been trained in Mifepristone-only (6%) or the recommended combination of 
Mifepristone and Misoprostol regimens (9%). 
 
Figure 2: Per cent distribution of pharmacy workers who had been trained on provision of abortion services by specific 
methods 
  
Notes: Multiple responses allowed; Number of cases=32. 
 
 
Availability of Abortion Services 
 
More than half (58%) of the pharmacy workers interviewed indicated that they provided advice or information 
on pregnancy termination to clients seeking the services although there were wide variations by county (65% 
in Kisumu, 29% in Nairobi and 84% in Mombasa). The most commonly provided information were referral to 
a health facility (71%), continuing with the pregnancy (60%), and seeking counselling services on how to 
manage the pregnancy (36%). Only 4% of the pharmacy workers reported that they provided methods of 
pregnancy termination to clients seeking the services (1% each in Kisumu and Mombasa and 9% in Nairobi). 
Nine out of ten provided Misoprostol only. Ninety five per cent of the pharmacy workers whose outlets 
provided abortion information or methods indicated that they sold family planning methods as well, which 
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provides an opportunity to offer such clients the methods. The most commonly sold methods in these outlets 
were pills (95%), male condoms (91%), emergency contraceptives (89%), and the 3-month injectables (75%). 
 
Among pharmacies whose workers reported that they provided abortion information or methods, 18% 
indicated that they sold Misoprostol only, 2% sold Mifepristone only while none sold the combination of 
Mifepristone and Misoprostol. The most commonly reported reasons for selling the medications were for 
controlling peptic ulcers (68%), labour induction (28%), controlling postpartum haemorrhage (24%), and 
treating incomplete abortion (12%).  
 
About two-thirds (67%) of the pharmacy workers who reported that they did not provide abortion information 
or methods indicated that clients asked for those services. In most cases, they referred clients elsewhere 
(49%) or advised them against procuring an abortion (40%). Those who reported referring clients elsewhere 
mostly referred them to private health facilities (78%). Others made referrals to public health facilities (54%) 
and general practitioners (8%). 
 
Availability of Drugs and Supplies 
 
Among pharmacies that provided information or methods on abortion, the most commonly available supplies 
were policy on confidentiality of clients (89%), policy on record-keeping and reporting (87%), Misoprostol 
(66%), and referral mechanisms (52%). The least available items were Mifepristone (2%), WHO Technical 
and Policy Guidance on Safe Abortion and the National Standards and Guidelines for abortion care (Figure 
3). 
 
Figure 3: Per cent distribution of pharmacies providing abortion information or methods by availability of drugs and 
supplies 
 
Notes: Multiple responses allowed; Number of cases=138. 
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Prices of Medical Abortion Methods 
 
The average price of Misoprostol based on information obtained from pharmacy workers ranged from KSh. 
74 (≈US $0.87) to KSh. 530 (≈US $6) depending on the brand (Table 1). The average price of Mifepristone 
was KSh. 73 (≈US $0.86). However, the prices quoted for simulated clients were much higher, ranging from 
KSh. 391 (≈US $4.60) to KSh. 2,116 (≈US $24) depending on the scenario presented (Table 1). 
 
Table 1: Minimum, maximum, and median prices of medical abortion methods in private pharmacies 
 
 
Method 
Minimum 
(KSH) 
Maximum 
(KSH) 
Median 
(KSH) 
Number of 
pharmacies 
Prices given by pharmacy workers 
Brands of Misoprostol     
    Misoclear 30 300 60 38 
    Cytotec-pharmacia UK 35 350 100 54 
    Isovent 50 120 60 9 
    Arthrotec 50 2,890 55 6 
Mifepristone Linepharma 200mg 65 80 73 2 
 Prices quoted for simulated clients 
Misoprostol only     
    Scenario 1 50 3,000 100 23 
    Scenario 2 200 4,000 800 7 
    Scenario 3 280 3,500 2,500 5 
    Scenario 4 320 5,000 1,000 11 
    All four scenarios 50 5,000 450 46 
Mifepristone only 400 1,000 700 2 
Notes: Standard deviations for means are in parentheses; KSH: Kenya shilling (1 USD ≈ KSH. 85). 
 
 
Knowledge and Attitudes of Pharmacy Workers 
 
Misoprostol alone was the most commonly known abortion medication among private pharmacy providers 
(86% of males and 76% of females) followed by Mifepristone alone (46% of males and 28% of females) while 
the combination of Mifepristone and Misoprostol was the least known (Figure 4). However, only 22% of males 
(N=103) and 16% of females (N=86) who had heard of the medications mentioned the correct regimen for 
Misoprostol only for pregnancies of various gestational ages. Similarly, only 13% of males (N=55) and 3% of 
females (N=32) mentioned the correct regimen for combination of Mifepristone and Misoprostol (Figure 4). 
A small proportion (3%) of the pharmacy workers felt that clients seeking abortion services should be able 
to get the drugs from pharmacies without a prescription. 
 
Figure 4: Per cent distribution of pharmacy workers by knowledge and attitudes regarding abortion 
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Service Provision Practices 
 
Slightly more than a quarter (27%) of pharmacy workers whose outlets provided abortion information or 
methods reported ever denying clients the services (32% of males and 20% of females; Table 2). The most 
common reasons for denying clients the services were religious or moral beliefs (57%), lack of trained 
provider (38%), lack of permission from third parties (19%), lack of appropriate equipment (14%), and lack 
of prescription from a medical practitioner (11%). In addition, 35% of pharmacy workers whose outlets 
provided abortion information or methods indicated that they screened clients (31% of males and 40% of 
females) while 7% advised clients to return for follow-up visits (8% of males and 7% of females; Table 2). 
Screening of clients mostly involved asking for reasons of seeking to terminate pregnancy, asking about 
gestational age of the pregnancy, asking about client’s background characteristics, conducting medical 
examination, asking for prescription, asking about medical history, and asking for proof of permission from 
third parties (not shown). 
 
Table 2: Per cent distribution of pharmacy workers by practices regarding abortion 
 
Indicator 
Male 
(%) 
Female 
(%) 
Both sexes 
(%) 
Instances of pharmacy denying abortion clients 
servicesa 
32.1 
(N=78) 
20.0 
(N=60) 
26.8 
(N=138) 
Reasons for denying abortion clients services (N=25) (N=12) (N=37) 
    Lack of prescription 4.0 25.0 10.8 
    Lack of permission from third parties 24.0 8.3 18.9 
    Client could not afford to pay 4.0 8.3 5.4 
    Stock-out of essential drugs 8.0 0.0 5.4 
    Lack of appropriate equipment 12.0 16.7 13.5 
    No trained provider 40.0 33.3 37.8 
    Religious/moral beliefs 64.0 41.7 56.8 
Providera (N=78) (N=60) (N=138) 
    Screens clients seeking abortion services 30.8 40.0 34.8 
    Advises clients to return for follow-up 7.7 6.7 7.3 
Notes: aAmong pharmacies providing information or services on abortion. 
 
 
 
With respect to interactions with simulated clients, there were significant variations in the practices of 
pharmacy workers by the scenario presented. In particular, the proportion of visits for which pharmacy 
workers asked about the last menstrual period, gestational age, medical history, reasons for pregnancy 
termination, and proof of permission from third parties were highest when simulated clients sought 
medication to terminate a three-month pregnancy (scenario 4) and lowest when they just asked for 
Misoprostol without stating reason (scenario 1; Table 3). Similarly, the proportion of visits for which pharmacy 
workers advised clients to continue with the pregnancy or gave information about where to obtain pregnancy 
termination services, available methods of pregnancy termination, and surgical abortion methods were 
highest under scenario 4 and lowest under scenario 1. By contrast, the proportion of visits for which providers 
asked for prescriptions from a medical practitioner and discussed medical abortion methods was highest 
under scenario 1 (Table 3).  
 
For all visits combined, pharmacy workers performed poorly on all indicators; the highest scores were for 
asking about gestational age (55%) and advising clients on where to obtain services for pregnancy 
termination (50%). In addition, despite the fact that most pharmacies providing abortion information or 
services also sold family planning methods, family planning was discussed with simulated clients in only 
12% of the visits (Table 3). Similarly, pharmacy workers recommended family planning in 9% of visits, offered 
a method in 1% of visits, and referred clients elsewhere for family planning in 1% of visits (Table 3). 
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Table 3: Per cent distribution of simulated client visits to private pharmacies by indicators of service provision and scenario presented 
 
 
 
 
Indicator 
Client asked for 
Misoprostol without 
stating reason: 
scenario 1  
(%) 
Client sought help to 
terminate pregnancy 
without stating 
gestational age: 
scenario 2 (%) 
Client sought 
medication to 
terminate 2-month 
pregnancy: scenario 
3 (%) 
Client sought 
medication to 
terminate 3-month 
pregnancy: scenario 4 
(%) 
 
 
All four scenarios 
(%) 
History-taking and medical examination      
    Provider asked about last menstrual period 6.9 39.0 32.7 74.8** 38.2 
    Provider asked about gestational age of pregnancy 28.7 50.0 75.3 64.7** 54.6 
    Provider asked about medical history 0.0 6.0 2.0 18.2** 6.5 
    Provider asked about reasons for terminating pregnancy 13.9 57.0 48.5 65.7** 46.1 
    Provider asked about prescription  44.6 24.0 13.9 33.3** 28.9 
    Provider asked about permission from third parties 0.0 3.0 12.9 28.3** 11.0 
    Provider conducted medical examination 3.0 4.0 5.0 7.1 4.7 
Counselling      
    Provider advised to continue with pregnancy 9.9 45.0 24.8 59.6** 34.7 
    Provider advised to seek counselling before abortion 16.8 12.0 6.9 28.3** 16.0 
    Provider advised where to obtain abortion services 27.7 50.0 53.7 69.7** 50.1 
    Provider advised about available abortion methods 6.9 37.0 28.7 50.5** 30.7 
    Provider discussed any surgical abortion method 5.0 29.0 26.7 50.5** 27.7 
    Provider discussed any medical abortion method 48.5 19.0 14.9 20.2** 25.7 
    Provider discussed family planning 5.9 7.0 18.8 16.2** 12.0 
    Provider recommended family planning 5.0 7.0 10.9 12.1 8.7 
    Provider referred client elsewhere for family planning 0.0 1.0 0.0 3.0* 1.0 
Services      
    Provider offered surgical abortion method 2.0 5.0 11.9 11.1* 7.5 
    Provider offered medical abortion method 5.9 10.0 5.9 12.1 8.5 
    Provider offered medication to manage pain 2.0 1.0 11.9 6.1** 5.2 
    Provider offered medication for complications 2.0 1.0 12.9 5.1** 5.2 
    Provider offered family planning method 0.0 1.0 0.0 1.0 0.5 
Notes: Differences between scenarios are statistically significant at: *p<0.05; **p<0.01. 
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SUMMARY AND IMPLICATIONS 
 
Summary of Findings 
 
 Very few pharmacy workers (16%) whose outlets provided abortion information or methods had been trained on 
the provision of the services with trainings focusing more on ensuring confidentiality and privacy of clients, history 
taking, and pain management, and less on the national standards and guidelines, record-keeping and reporting, 
criteria for referral procedures and the recommended regimens for combination of Mifepristone and Misoprostol. 
 
 There was limited stocking of Misoprostol or Mifepristone even in pharmacies that provided abortion information 
or methods with only 18% of such pharmacies selling Misoprostol, 2% sold Mifepristone while none sold the 
combination of Mifepristone and Misoprostol. In addition, most of the pharmacies did not have the national 
standards and guidelines document on reducing maternal mortality and morbidity from unsafe abortion. 
 
 There was limited knowledge of the correct regimen for Misoprostol only (22% of males and 16% of females) or 
for combination of Mifepristone and Misoprostol (13% of males and 3% of females) for pregnancies of various 
gestational ages among pharmacy workers who knew about the medications. 
 
 Although nearly all pharmacy workers (97%) felt that clients seeking Mifepristone and Misoprostol from 
pharmacies should have a prescription from a medical practitioner, only 11% indicated having ever denied clients 
abortion services because of lack of a prescription while the most common reasons for denial of services were 
religious or moral beliefs or lack of a trained provider. 
 
 Pharmacy workers performed poorly on all indicators of interactions with simulated clients although the chances 
of asking about gestational age (55% of interactions) and advising clients on where to obtain services for 
pregnancy termination (50% of interactions) were higher than those of discussing family planning (12% of 
interactions), recommending family planning (9% of interactions), offering a method (1% of interactions), or 
referring clients elsewhere for family planning (1% of interactions). 
 
Implications 
 
 There is need to improve the capacity of pharmacy workers to offer appropriate information including proper use 
of medication, family planning and referrals to clients seeking abortion services. 
 
 There is need to improve the supply chain to reduce stock-outs of essential drugs (especially combined 
Mifepristone and Misoprostol) in private pharmacies that provide abortion information or methods. 
 
 There is need for widespread dissemination of the existing policies and guidelines among pharmacy workers to 
ensure that they provide services within existing regulations. 
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Abortion Services in Private Clinics  
 
INTRODUCTION 
 
Private clinics in Kenya are operated by the cadres of providers that fall within the legal definition of a health 
professional including doctors, clinical officers, nurses and midwives. The clinics are registered by the Kenya Medical 
Practitioners and Dentists Board, the Clinical Officers Council or the Nursing Council of Kenya depending on the 
qualification of the provider operating the clinic. It is also common for private providers to be part of a network or 
franchise that aims at improving institutional sustainability of the clinics and the quality of care that they provide. In 
spite of the regulatory and institutional oversight available for private clinics in the county, the nature of care provided 
at the outlets may still be affected by other factors such as the resources at the disposal of the provider, availability 
of appropriate services, choices that clients make, technical competence of providers as well as how they interact 
with clients including mechanisms for follow-up (Bruce 1990).  
 
In the context of abortion services, care at private clinics may be affected by some of the challenges identified by key 
informants (see section on “Abortion Environment”) including inadequate training, limited awareness about relevant 
policies and guidelines, poor supply and distribution chain for essential medicines, and the social stigma associated 
with the practice. However, little is known about the provision of medical abortion in private clinics in the country, the 
acceptability of the practice among providers and clients, as well as the content of care given to clients. The objectives 
of this component of the study were: 
1) To assess the availability of Mifepristone and Misoprostol or other abortifacient as well as the skills and 
practices of providers in private clinics; 
2) To examine the knowledge and attitudes of providers in private clinics regarding Mifepristone and Misoprostol 
or other abortifacients; 
3) To determine the characteristics, choices and perceptions of clients seeking abortion services from private 
clinics; and 
4) To explore the quality of care given to clients seeking abortion services from private clinics. 
 
METHODOLOGY 
 
This component of the study involved structured interviews with in-charges (managers) of private clinics, observations 
of client-provider interactions during consultations, and structured exit interviews with clients seeking abortion 
services. 
 
Interviews with Facility In-charges  
 
Structured interviews were conducted with facility in-charges of 45 private clinics that provide abortion services (11 
in Kisumu, 18 in Nairobi, and 16 in Mombasa). The facilities were randomly sampled from among those that were 
members of the Reproductive Health Network and/or the AMUA Franchise that is managed by Marie Stopes Kenya. A 
minimum of 10 facilities were targeted in each County. The interviews with the in-charges included an inventory to 
determine the available infrastructure, staffing levels and skills mix, equipment, commodities, and supplies needed 
for surgical and medical abortion services. The facility in-charges were also asked about their knowledge and practices 
as well as the prices of abortion services available at the facility. Almost one-half (47%) of the in-charges were nurses 
or midwives, 36% were clinical officers, 9% were gynaecologists, and 9% were community health workers. Two-thirds 
of in-charges were male. On average, the providers had worked in health care for 19 years, although females had 
worked longer (average of 24 years) compared to males (average of 16 years).The providers had worked at the 
facilities where they were interviewed for an average of 9 years with females having worked slightly longer (11 and 7 
years respectively).  
 
Observations of Client-Provider Interactions  
 
Observations of client-provider interactions during consultations were in conducted in private clinics with clients and 
providers who had given their consent to be observed during the provision of a medical abortion procedure. A total of 
141 observations were conducted in 32 out of the 45 private clinics that were included in the study (62 in 11 clinics 
in Kisumu, 58 in 12 clinics in Nairobi and 21 in 9 clinics in Mombasa). Two observations were partially completed (1 
in Kisumu and 1 in Mombasa) because the clients needed referrals to higher level facilities. The observations were 
conducted by trained nurses to determine the nature and quality of services that clients received. The nurses used a 
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structured checklist adapted from the WHO Technical and Policy Guidance on Safe Abortion (WHO 2012) and the 
National Standards and Guidelines for Reducing Morbidity and Mortality from Unsafe Abortion in Kenya (Republic of 
Kenya 2012). They observed aspects of history taking, pre-procedure counselling, medical examination, provision of 
medical abortion, and post-abortion care information provided to clients. 
 
Client Exit Interviews 
 
Immediately after the observations, consenting clients were requested to participate in an exit interview to determine 
their perceptions of the services provided and their overall impression of the provider’s behaviour during the 
consultation. Interviews were completed with 125 clients (48 in 11 clinics in Kisumu, 56 in 12 clinics in Nairobi and 
21 in 9 clinics in Mombasa). Six interviews were partially completed and eight clients who were observed during the 
consultation refused the interview. Information was collected on their background characteristics (such as age, 
education level, marital status, religious affiliation, and household assets and amenities), childbearing experiences 
and intentions, family planning knowledge and use, and perceptions about the services received. The interviews were 
conducted in English, Kiswahili or a mixture of both depending on the clients’ preference by a research assistant who 
was paired with the nurse conducting the observations. 
 
Data Analysis 
 
All data were entered in EpiData and analysed using STATA. Analysis involved simple descriptive statistics including 
percentages, means and medians. Composite scores were computed to determine availability of drugs and supplies 
as well as the quality of care that clients received. The results are presented in the form of the fraction of elements 
that were available in the clinics or that were performed by providers during interactions with clients. Tables A1 and 
A2 in the Appendix present the list of items that were used to compute the scores for service availability and quality 
of care respectively. 
 
RESULTS 
 
Staffing Levels and Staff Training 
  
The clinics had, on average, 4 medical and 1 support staff, with facilities in Nairobi having the highest median number 
of providers, followed by those in Mombasa and Kisumu (Table 4). However, facilities had on average only 1 staff 
member trained on medical abortion, comprehensive post-abortion care or family planning, while none was trained 
on values clarification and attitude transformation. Facilities in Kisumu had higher numbers of staff members trained 
on medical abortion and family planning (Table 4). Further analysis showed that the most common aspects related to 
the provision of abortion services that clinic staff had received in-service training on were infection prevention (78% 
of facilities), referral procedures (76%); and managing complications (76%; not shown). The least aspects that staff 
had been trained on were the national standards and guidelines (60% of facilities) and the legal and policy provisions 
regarding abortion (51%; not shown). Other aspects that staff had been trained on included pregnancy screening (67% 
of facilities), communication/counselling (69%), medical examination of clients (69%), history taking (71%), pain 
management (71%), record-keeping/reporting (71%), and confidentiality/privacy of clients (73%; not shown).  
 
Table 4: Staffing levels and staff training in private clinics 
 
Indicator 
Kisumu 
(N=11) 
Nairobi 
(N=18) 
Mombasa 
(N=16) 
All sites 
(N=45) 
Median number of staff in facility     
    Medical staff 3 5 4 4 
    Support staff 2 1 2 1 
    All staff 3 6 5 5 
Median number of staff trained on specific aspects     
    Medical abortion 2 1 1 1 
    Comprehensive post-abortion care 1 0 1 1 
    VCAT 0 0 0 0 
    Family planning 2 1 1 1 
Notes: VCAT: Values clarification and attitude transformation. 
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Service Availability 
 
Eighty per cent of the clinics offered at least one surgical abortion method and a similar proportion offered at least 
one medical abortion method (Table 5). MVA was the most common surgical abortion method, while Misoprostol alone 
was the most common medical abortion method available in the clinics. Almost all (91%) facilities offered either 
surgical or medical abortion methods, while 69% offered both methods. Only 11% of the facilities had Mifepristone 
alone, while 18% had a combination of Mifepristone and Misoprostol, reflecting the fact that Mifepristone had just 
been registered a few months before the study. 
 
More than 90% of facilities conducted or had conducted at least one procedure related to pre-abortion, pain 
management, infection prevention or control, and management of complications (Table 5). However, only 33% of 
facilities conducted all the procedures related to pre-abortion care, while none had conducted all the procedures 
related to pain management, infection prevention or control, and management of complications. Virtually all facilities 
(98%) reported that they provide family planning information or methods as a separate service. However, only 53% 
reported that they provide additional information on when to seek further care and less than half reported providing 
information on prevention of sexually transmitted infections (STIs) or HIV (49%), self-care after leaving the health 
facility (42%), and resumption of sexual activity (15%; ). 
 
Table 5: Per cent distribution of facilities offering various abortion-related services by study site 
 
 
Service indicator 
Kisumu 
% 
(N=11) 
Nairobi 
% 
(N=18) 
Mombasa 
% 
(N=16) 
All sites 
% 
(N=45) 
Surgical abortion methods     
    Manual vacuum aspiration 54.6 72.2 87.5 73.3 
    Electric vacuum aspiration 9.1 5.6 0.0 4.4 
    Dilatation and evacuation 27.3 22.2 0.0 15.6 
    Dilatation and curettage 27.3 27.8 6.3 20.0 
    Hysterotomy 9.1 0.0 0.0 2.2 
    Any surgical abortion method 72.7 77.8 87.5 80.0 
    All surgical abortion methods 0.0 0.0 0.0 0.0 
Medical abortion methods     
    Misoprostol (Miso) alone 81.8 50.0 93.8* 73.3 
    Mifepristone (Mife) alone 0.0 5.6 25.0 11.1 
    Combination of Mife and Miso 27.3 11.1 18.8 17.8 
    Any medical abortion methods 90.9 61.1 93.8 80.0 
Surgical and/or medical methods     
    Surgical or medical methods 90.9 83.3 100.0 91.1 
    Surgical and medical methods 72.7 55.6 81.8 68.9 
Pre-abortion processes (4 items)a     
    Any process (at least 1 item) 100.0 94.4 87.5 93.3 
    All processes (all 4 items) 45.5 22.2 37.5 33.3 
Pain management procedures (6 items)a      
    Any procedure (at least 1 item) 100.0 100.0 100.0 100.0 
    All procedures (all 6 items) 0.0 0.0 0.0 0.0 
Infection prevention and control (6 items)a     
    Any process (at least 1 item) 100.0 83.3 100.0 93.3 
    All processes (all 6 items) 0.0 0.0 0.0 0.0 
Management of complications (8 items)a     
    Any procedure (at least 1 item) 100.0 94.4 93.8 95.6 
    All procedures (all 8 items) 0.0 0.0 0.0 0.0 
Family planning     
    Information 100.0 100.0 93.8 97.8 
    Methods 100.0 100.0 93.8 97.8 
Other information services     
    When to seek further care 63.6 50.0 50.0 53.3 
    Prevention of STIs/HIV  72.7 33.3 50.0 48.9 
    Self-care after leaving facility 54.6 27.8 50.0 42.2 
    Resumption of sexual activity 36.4 5.6 6.3* 14.9 
Notes: aSee Table A1 in the Appendix section for the list of items; STIs: Sexually transmitted infections; Differences between study 
 sites are statistically significant at: *p<0.05; **p<0.01. 
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Availability of Drugs, Supplies and Equipment 
 
Interviewers asked facility in-charges and also requested to see whether various drugs, supplies and equipment for 
abortion services were available at the facility and in stock on the day of the visit. The clinics had most of the drugs 
and supplies for surgical abortion (81% of items) as well as for recovery, pain management and treatment of 
complications (85% of items; Table 6). However, the proportions of these items that were in stock on the day of 
interview were lower than what was reported to be available. The clinics also had most of the infrastructural facilities 
needed to ensure quality care for clients (91% of items; Table 6). The facilities also had about two-thirds of the 
equipment for surgical or medical abortion (68% of items) and services standards and guidelines on abortion (69% of 
items). Availability of drugs and supplies for medical abortion at the clinics was very low (15%) although the proportion 
of items that were in stock on the day of interview was similar to what was reported to be available (Table 6).   
 
Table 6: Availability of drugs, supplies, and equipment by study site 
 
Indicator 
Kisumu 
(%) 
(N=11) 
Nairobi 
(%) 
(N=18) 
Mombasa 
(%) 
(N=16) 
All sites 
(%) 
(N=36) 
Drugs and supplies for surgical abortion (16 items)     
    Available in facility 85.2 74.3 84.4 80.6 
    In stock on day of visit 81.8 72.3 55.1 68.8 
Drugs and supplies for medical abortion (10 items)     
    Available in facility 16.4 10.6 18.1 14.7 
    In stock on day of visit 16.4 10.6 18.1 14.7 
Drugs and supplies for recovery, pain management and 
complications (6 items) 
    
    Available in facility 89.4 83.3 84.4 85.2 
    In stock on day of visit 78.8 79.6 78.1 78.9 
Equipment for surgical or medical abortion (21 items)     
    Available in facility 78.4 55.8 74.7 68.0 
    In stock on day of visit 71.8 54.0 69.6 63.9 
Service standards and guidelines (5 items) 74.5 58.9 76.3 68.9 
Infrastructure scores (9 items) 94.9 92.0 86.1 90.6 
 
 
 
Provider Knowledge and Attitudes 
 
Knowledge, attitudes and practices of facility managers are likely to influence the provision of abortion services at 
health facilities. Facility in-charges were asked about the common legal grounds for procuring induced abortion in the 
country and whether permission from third parties is required before performing abortion. Providers mostly cited 
health reasons (64% of providers), preservation of life (43% of providers), and low socio-economic status of clients 
(30%) as the common legal grounds for induced abortion (table 7). About a quarter (23%) of the providers noted that 
induced abortion can be provided on request, which is contrary to existing laws and regulations. Slightly more than 
half (55%) of the providers reported that permission from third parties (mostly from parents/ guardians or 
spouses/partners) is needed before performing abortion. About half (49%) of providers whose facilities stocked 
Misoprostol mentioned the correct regimen for pregnancies of various gestational ages (Table 7) while all providers 
whose clinics stocked the combination of Mifepristone and Misoprostol mentioned the correct regimen (not shown).  
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Table 7: Per cent distribution of facility in-charges by knowledge, attitudes and service provision practices regarding 
abortion 
 
Indicator 
Male 
(%) 
Female 
(%) 
Both sexes 
(%) 
Knowledge of legal grounds for induced abortiona  (N=28) (N=16) (N=44) 
    On request 21.4 25.0 22.7 
    Low socioeconomic status 32.1 25.0 29.6 
    Health reasons 64.3 62.5 63.6 
    Rape 25.0 31.3 27.3 
    Incest 25.0 25.0 25.0 
    Preservation of woman’s life 46.4 37.5 43.2 
Third party permissions required for abortionb (N=28) (N=16) (N=44) 
    No 42.9 37.5 40.9 
    Yes 53.6 56.3 54.6 
    Don’t know 3.6 6.3 4.6 
Persons whose permissions are requireda (N=15) (N=9) (N=24) 
    Parent/guardian 66.7 66.7 66.7 
    Spouse/partner 66.7 77.8 70.8 
    Medical Commissions 13.3 11.1 12.5 
    More than 1 specialist/physician 20.0 0.0 12.5 
    Other 13.3 11.1 12.5 
Correctly explained Misoprostol-only regimen for 
pregnancies of different gestational ages 
55.0 
(N=20) 
38.5 
(N=13) 
48.5 
(N=33) 
Notes: aMultiple responses; bPercentages may not sum to 100 due to rounding. 
 
 
Service Provision Practices 
 
About three-quarters (78%) of the providers reported that there were instances when their facilities denied abortion 
clients the services. The most common reasons were because they could not afford to pay (46%), inappropriate 
gestational age (34%), clients’ health status was not conducive (20%), and lack of appropriate equipment (20%; Figure 
5). A significantly higher proportion of male compared to female providers reported inappropriate gestational age as 
the reason for denying abortion clients the services while a significantly higher proportion of female than male 
providers reported stock-outs and religious or moral concerns as reasons for denying abortion clients services (p<0.05 
in each case). 
 
Figure 5: Reasons for denying abortion clients services 
 
Notes: Number of cases: Males=24; Females=11.  
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With respect to observations of client-provider interactions during consultations, the most commonly performed 
elements were courteous handling of clients (74% of elements performed) and provision of pre-abortion information 
(60% of elements performed; Table 8). The least provided services were providing recommendations following medical 
examination of clients (17% of elements performed), counselling on family planning (40% of elements performed), 
and conducting medical examination (45% of elements performed). In all cases, the performance of the elements was 
highest in Kisumu and lowest in Nairobi (Table 8). 
 
Table 8: Indicators of quality of abortion services in private clinics 
 
Indicator 
Kisumu 
% 
(N=62) 
Nairobi 
% 
(N=58) 
Mombasa 
% 
(N=21) 
All sites 
% 
(N=141) 
History taking (14 items) 61.4 51.5 59.2 57.0 
Courteous handling of clients (11 items) 81.4 65.3 78.8 74.4 
Provision of pre-abortion information (8 items) 71.4 48.7 57.7 60.0 
Medical examination (15 items) 49.4 40.3 43.2 44.7 
    Oral examination (6 items) 46.8 35.9 56.3 43.7 
    Physical examination (9 items) 51.1 43.3 34.4 45.4 
Post-examination recommendations (10 items) 25.5 9.1 12.4 16.8 
Post-abortion care counselling (6 items) 61.3 38.5 55.6 51.1 
Counselling on family planning (5 items) 62.3 18.3 34.3 40.0 
Overall quality of care (69 items) 87.8 62.4 74.6 75.4 
 
 
Further analysis showed that providers recommended MVA to clients in 57% of the consultations, Misoprostol alone 
in 30% of the consultations, and combination of Mifepristone and Misoprostol in 9% of the consultations (not shown). 
Distribution by gestational age showed that providers recommended MVA for 54% of pregnancies of up to 9 weeks, 
59% of pregnancies above 9 and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% of 
pregnancies over 14 weeks (not shown). In addition, providers recommended the correct regimen for gestational age 
in only 31% of consultations in which medical abortion (Misoprostol alone or combination of Mifepristone and 
Misoprostol) was recommended. For 43 consultations in which Misoprostol alone was recommended, providers 
explained the mode of action in 88% of the cases, and for the 12 consultations where combination of Mifepristone 
and Misoprostol was recommended, providers explained the mode of action in 11 cases (not shown).  
 
Almost all clients (93%) were given post-abortion care medication with the highest in Nairobi and lowest in Mombasa 
(Figure 6). Although 98% of facilities indicated that they provided family planning information or methods (Table 5), 
clients were counselled on family planning in 79% of the consultations and offered family planning methods in only 
48% of consultations, with wide variations between study sites. Few clients were referred to another facility for further 
help (13% of consultations). 
 
Figure 6: Distribution of consultations by provision of specific abortion-related services 
 
Notes: Number of cases: Kisumu=62; Nairobi=58; Mombasa=21. 
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Characteristics of Clients Seeking Abortion Services 
 
The majority of clients who were observed during consultation and interviewed upon exit were aged between 20 and 
29 years (66%; Table 9). Whereas more than half of the clients in Kisumu (54%) and Mombasa (52%) had primary 
level education or lower, the majority in Nairobi (64%) had college-level education. Nearly three-quarters (73%) of the 
clients in Kisumu were from the two poorest wealth quintiles, 57% of clients in Nairobi were from the two richest 
wealth quintiles, and a similar proportion of clients in Mombasa were from the middle and richer quintiles. Many 
clients (59%) were never married although there were significant differences between study sites, with the majority of 
clients in Mombasa (43%) being formerly married (separated, divorced or widowed). More than half (56%) of the clients 
had been pregnant more than once (Table 6) while 54% had not given birth. Among those who had given birth, 53% 
had two or more living children. Sixty per cent of the clients had intention to have children in future while the majority 
(78%) desired fewer than 5 children. 
 
Table 9: Background characteristics of clients seeking abortion services 
 
 
Characteristics 
Kisumu 
% 
(N=48) 
Nairobi 
% 
(N=56) 
Mombasa 
% 
(N=21) 
All sites 
% 
(N=125) 
Age group p=0.86    
    <20 years 16.7 10.7 19.1 14.4 
    20-29 years 62.5 69.6 61.9 65.6 
    30 years and above 20.8 19.6 19.1 20.0 
Highest education level p<0.01    
    Primary or lower 54.2 14.3 52.4 36.0 
    Secondary 33.3 21.4 42.9 29.6 
    College/university 12.5 64.3 4.8 34.4 
Marital status p<0.01    
    Never married 60.4 66.1 38.1 59.2 
    Married/living together 29.2 28.6 19.1 27.2 
    Formerly marrieda 10.4 5.4 42.9 13.6 
Religious affiliation p<0.01    
    Catholic 35.4 32.1 9.5 29.6 
    Protestant/other Christian 64.6 57.1 61.9 60.8 
    Muslim/no religion 0.0 10.7 28.6 9.6 
Household wealth index p<0.01    
    Poorest quintile 39.6 5.4 19.1 20.8 
    Poorer quintile 33.3 10.7 19.1 20.8 
    Middle quintile 14.6 26.8 23.8 21.6 
    Richer quintile 8.3 26.8 33.3 21.6 
    Richest quintile 4.2 30.4 4.8 15.2 
Number of times pregnant p=0.83    
    Once 45.8 44.6 38.1 44.0 
    More than once 54.2 55.4 61.9 56.0 
Children ever born p=0.59    
    0 54.2 55.4 47.6 53.6 
    1 16.7 19.6 33.3 20.8 
    2 and above 29.2 25.0 19.1 25.6 
Number of living childrenb p=0.53    
    0 4.8 8.0 0.0 5.3 
    1 38.1 36.0 63.6 42.1 
    2 and above 57.a 56.0 36.4 52.6 
Intention to have children in future p=0.09    
    No 25.0 28.6 14.3 24.8 
    Yes 66.7 48.2 76.2 60.0 
    Don’t know/up to God 8.3 23.2 9.5 15.2 
Number of desired children p<0.01    
    1-2 47.9 30.4 19.1 35.2 
    3-4 45.8 32.1 61.9 42.4 
    5 and above 4.2 3.6 14.3 5.6 
    Don’t know/up to God 2.1 33.9 4.8 16.8 
Notes: aSeparated/divorced/widowed; bAmong those who had ever given birth; p-values are from Chi-square tests of differences 
between study sites. 
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Clients’ Experiences and Need for Abortion Services 
   
Clients who had been pregnant more than once were asked about their previous experiences with miscarriages, still 
births and abortions. Twenty per cent of them reported having a previous miscarriage or still birth with a significantly 
lower proportion of clients in Kisumu (4%) compared to those in Nairobi (26%) and Mombasa (39%) reporting such 
experiences (Table 10). The majority (86%) who had more than one pregnancy reported having a previous abortion, 
with significant differences between study sites.  
 
During consultations, observers noted whether the provider asked clients the reasons for wanting to terminate the 
pregnancy, and if so, the explanations that clients gave. Providers asked for such reasons in 83% of the consultations. 
The most commonly given reasons were that the pregnancy was unplanned (73%), the need to continue with education 
(24%), family pressure (14%), and the need to continue with employment (14%; Table 10). Interestingly, only two 
percent of pregnancies were a result of family planning method failure (not shown).  
 
Observers further noted whether the provider established and recorded the gestational age of the pregnancy. 
Providers established the gestational age of the pregnancy in 90% of the consultations with more than half (59%) of 
clients seeking abortion services at 9 weeks and below while 10% sought services at more than 14 weeks of pregnancy 
(Table 10). 
 
Table 10: Per cent distribution of clients seeking abortion services by previous experiences, rationale for and 
gestational age at the time of seeking care 
 
Indicator 
Kisumu 
(%) 
Nairobi 
(%) 
Mombasa 
(%) 
All sites 
(%) 
Any previous miscarriages or still birthsa (N=26) (N=31) (N=13)* (N=70) 
    No 96.2 74.2 61.5 80.0 
    Yes 3.9 25.8 38.5 20.0 
Number of previous abortionsa (N=26) (N=31) (N=13)** (N=70) 
    0 34.6 3.2 0.0 14.3 
    1 53.9 61.3 76.9 61.4 
    2 or more 11.5 35.5 23.1 24.3 
Reasons for seeking servicesb (N=53) (N=46) (N=17) (N=116) 
    Education/school 37.7 10.9 17.7** 24.1 
    Health reasons 13.2 10.9 0.0 10.3 
    Family pressure 26.4 2.2 5.9** 13.8 
    Employment-related  13.2 13.0 17.7 13.8 
    Unplanned/not ready for child 64.2 82.6 76.5 73.3 
Gestational age at time of seeking carec (N=49) (N=58) (N=19)* (N=126) 
    9 weeks and below 53.1 69.0 42.1 58.7 
    Above 9 and below 12 weeks 22.5 22.4 15.8 21.4 
    Between 12-14 weeks 14.3 5.2 15.8 10.3 
    Over 14 weeks 10.2 3.5 26.3 9.5 
Notes: aAmong those with two or more pregnancies; bBased on observations of client-provider interactions for consultations where 
 the provider asked for reasons for wanting to terminate pregnancy; cBased on observations of client-provider interactions 
 for consultations where the provider determined the gestational age of pregnancy; Differences between study sites are 
 statistically significant at: *p<0.05; **p<0.01. 
 
   
 
Clients’ Knowledge and Use of Family Planning 
 
Clients seeking abortion services were asked about their knowledge and prior use of family planning methods. Ninety 
eight per cent of the clients reported knowing a family planning method with no significant differences between study 
sites. The majority (78%) reported having ever used a family planning method with no significant differences between 
study sites. The most common methods clients had ever used were male condom, oral pills, injectables, and 
emergency pill (Figure 7). 
 
  
24 
Figure 7: Per cent distribution of clients who had ever used a family planning method by type of method 
 
Notes: IUCD: Intra-uterine contraceptive device; Number of cases=97. 
 
 
Eighty percent of the clients who had ever used family planning obtained a method themselves or together with their 
partners the last time, while 19% reported that their partners obtained the method. Among clients who obtained a 
method by themselves or together with their partners, 36% got it from private pharmacies, 35% from private health 
facilities, and 22% from public health facilities (Figure 8). 
 
Figure 8: Distribution of clients by source of family planning method 
 
Notes: Number of cases=78. 
 
 
Upon exit, clients were asked whether they decided to use a family planning method and if so, which method. Nearly 
two-thirds (63%) chose a family planning method, most commonly injectables (40%), male condoms (33%), pills (20%), 
implants (18%), and IUCDs (18%). Eleven per cent of these clients had not previously used family planning while 
among those who had previously used a method, 60% chose a different method. Figure 9 shows a dramatic decline 
in the use of oral pills and increases in the use of injectables, IUCD and implants among clients who had previously 
used a method. 
 
  
44
40
35
26
8
6
2
1
0 10 20 30 40 50
Male condom
Pills
Injectables
Emergency pill
Implants
IUCD
Female condom
Female sterilization
Percent
36
35
22
3
3
1
0 10 20 30 40 50
Pharmacy
Private health facility
Public health facility
Shop
Other
Friend/relative
Percent
  
25 
Figure 9: Distribution of clients by type of family planning method ever used and method accepted among those who accepted a 
different method from that previously used 
 
Notes: IUCD: Intra-uterine contraceptive device. 
 
 
 
Clients’ Perceptions of Services Received 
 
In all study sites, clients highly rated the consultation process with 96% of the elements reported as having been 
performed by the providers (Figure 10). By contrast, providing information on the services being given was the least 
rated component of the interactions with clients reporting only 58% of the elements being performed by the providers. 
Overall ratings of the consultation process and information provided were highest in Kisumu and lowest in Nairobi 
while rating for history taking and medical examination was highest in Kisumu and lowest in Mombasa (Figure 10).   
 
Figure 10: Indicators of client perceptions about services received 
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Clients were asked upon exit how long they waited before being seen by the provider from the time they arrived at the 
facility, and whether they felt that it was reasonable. Most clients (88%) reported that the waiting time was reasonable 
with no significant differences between study sites. The average waiting time was 13 minutes (9 minutes in Kisumu, 
16 minutes in Nairobi, and 17 minutes in Mombasa). Most (45%) clients waited between 10 and 29 minutes (Figure 
11) with wide variations between study sites. 
 
Figure 11: Per cent distribution of clients interviewed upon exit by waiting time before being seen by the provider 
 
 
 
 
 
Prices of Abortion Services 
 
Facility in-charges were asked about the prices of surgical and medical abortion services available at the clinics. The 
median cost of MVA was KSh. 3,000 (≈US $35) while that of dilatation and evacuation or dilatation and curettage was 
KSh. 5,000 (≈US $58; Table 11). The median price of the Misoprostol only regimen increased with higher gestation 
age of pregnancy while the median price for the combination of Mifepristone and Misoprostol for pregnancies of up 
to 9 weeks was KSh. 5,000 (≈US $58). There were wide variations in the prices facilities charge for the methods (Table 
11). One provider reported the price of KSh. 5,000 (≈US $58) for combination of Mifepristone and Misoprostol for 
pregnancies of gestational age of above 9 and below 12 weeks. 
 
Clients were asked upon exit how much they paid for  additional elements of abortion service, including transport, 
consultation card, laboratory tests, other medication, counselling, and family planning methods. The results in Table 
11 show that clients’ expenses on surgical abortion methods (MVA or dilatation and evacuation were quite high. In 
addition, consultation fee was, on average, higher than the cost of medication. 
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Table 11: Minimum, maximum and median prices of services in private clinics 
 
Services 
Minimum 
(KSH) 
Maximum 
(KSH) 
Median 
(KSH) 
Number of 
clinics 
Prices given by clinics 
Cost of surgical abortion methods     
    Manual vacuum aspiration 1,500 10,500 3,000 35 
    Dilatation and evacuation 3.500 15,000 5,000 7 
    Dilatation and curettage 3,500 10,000 5,000 6 
Cost of Misoprostol regimen     
    9 weeks and below 360 5,000 2,500 16 
    Above 9 and below 12 weeks 180 5,000 3,000 10 
    Between 12-14 weeks 90 7,000 4,500 6 
Cost of combination of Mife and Miso     
    9 weeks and below 1,000 7,000 5,000 5 
    Above 9 and below 12 weeksa --  -- 1 
 Expenses incurred by clients 
Client expenses on     
    Transport 10 800 70 67 
    Consultation 100 5,400 2,000 73 
    Card 50 8,500 50 17 
    Laboratory tests 99 400 200 25 
    Medication 200 6,500 1,400 22 
    Family planning method(s) 50 3,500 100 10 
    Manual vacuum aspiration 300 7,000 4,000 18 
    Miso and manual vacuum aspiration 3,500 5,000 4,250 2 
    Dilatation and evacuation 8,000 10,000 9,000 2 
Notes: aOne provider reported KSh. 5,000; KSH: Kenya shilling (1 USD ≈ KSH. 85). 
 
 
     
SUMMARY AND IMPLICATIONS 
 
Summary of Findings 
 
 The most common aspects related to the provision of abortion services that private providers had received in-
service training on were infection prevention (78% of facilities), referral procedures (76% of facilities); and 
managing complications (76% of facilities) while the least aspects were the national standards and guidelines 
(60% of facilities) and the legal and policy provisions regarding abortion (51% of facilities). 
 
 Availability of drugs and supplies for medical abortion was very limited (15% of items) although the proportion of 
items that were in stock on the day of interview was similar to what were reported to be available. By contrast, 
facilities had most of the drugs and supplies for surgical abortion (81% of items) as well as for recovery, pain 
management and treatment of complications (85% of items) although the proportions of items that were in stock 
on the day of interview were lower than what was reported to be available.  
 
 Although providers mostly cited health reasons (64% of providers) and preservation of the mother’s life (43% of 
providers) as the common legal grounds for induced abortion, about a quarter (23%) noted that induced abortion 
can be provided on request, which is contrary to existing laws and regulations. In addition, only about half (49%) 
of providers whose facilities stocked Misoprostol mentioned the correct regimen for pregnancies of various 
gestational ages. 
 
 Two-thirds (66%) of the women seeking abortion services from private clinics were aged between 20 and 29 years, 
64% had at least secondary level education, 59% were never married while 56% had a previous pregnancy, with 
the majority of those who had more than one pregnancy (86%) reporting having a previous abortion. 
 
 More than half (59%) of clients seeking abortion services had pregnancies of up to 9 weeks with the most common 
reason for seeking abortion services being that the pregnancy was unplanned (73%) while other reasons included 
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the need to continue with education (24%), family pressure (14%), and the need to continue with employment 
(14%). 
 
 Providers recommended the correct regimen for gestational age in only 31% of consultations in which medical 
abortion (Misoprostol alone or combination of Mifepristone and Misoprostol) was offered. By contrast, providers 
recommended manual vacuum aspiration for 54% of pregnancies of up to 9 weeks, 59% of pregnancies above 9 
and below 12 weeks, 31% of pregnancies between 12 and 14 weeks, and 58% of pregnancies over 14 weeks.  
 
 Although nearly all (98%) private clinics reported providing family planning information or methods, only 79% of 
the clients seeking abortion services were counselled on family planning while 48% were given a method. Besides, 
elements of family planning counselling were some of the least performed functions during consultations (40% of 
elements performed) while elements of interpersonal relationships such as courteous handling of clients were 
some of the most performed by providers (74% of elements performed). 
 
 The majority of clients seeking abortion services (78%) had previously used a family planning method, mostly 
male condom, oral pills, injectables, and emergency pill. Nearly two-thirds (63%) chose a method on the day of 
visit, mostly injectables (40%), male condoms (33%), pills (20%), implants (18%), and IUCDs (18%) while 60% of 
those who had a previously used a method chose a different method, mostly injectables, IUCD and implants. 
 
 Prices of medical abortion drugs increased with higher gestation age of pregnancy although there were wide 
variations in the prices facilities charge for the methods, ranging from KSh. 90 (≈US $1) to KSh. 7,000 (≈US $82). 
Prices of surgical abortion methods also varied widely between facilities from KSh. 1,500 (≈US $18) to KSh. 
15,000 (≈US $176). 
 
Implications 
 
 There is need for widespread dissemination of the existing policies and guidelines regarding abortion among 
private providers to ensure that they offer services within existing regulations. 
 
 There is need to improve the supply chain for medical abortion drugs (especially combined Mifepristone and 
Misoprostol) in private clinics. 
 
 There is need strategies to improve the capacity of private providers to offer appropriate family planning services 
to clients seeking abortion, especially long-term methods given the high rate of repeat abortions. 
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Study Limitations  
 
One of the limitations of the study stems from the technique of observing clients and providers during consultations 
as it is likely that providers may bias their behaviour in a positive way. To address this issue, all observers had medical 
qualifications as this was expected to raise the comfort levels of the providers such that their behaviours become 
normative. In addition, it was emphasized during training that at the beginning of the observation the observers should 
let the providers know that they were not there to evaluate them and that the observers were not experts who could 
be consulted during the session. 
 
A second limitation was that although facilities were randomly sampled from among those that were members of RHN 
or the AMUA Franchise, the clients were not randomly sampled as they were observed or interviewed upon exit based 
on their expressed willingness to participate voluntarily in the study.  It could be that those who accepted to participate 
in the study were self-selecting based on a greater willingness to share their experiences regarding this stigmatized 
behaviour and so their experiences may not be representative of all clients seeking abortion services from private 
health facilities. 
 
Another limitation stems from the unclear or ambiguous nature of the Kenyan legal status on abortion, which could 
have induced study participants, especially private pharmacy workers, to deny knowledge of the subject or to provide 
responses in line with the prevailing legal and socio-cultural context. In addition, given that written informed consent 
was obtained from the pharmacy proprietor in advance of the simulated client visits, he/she may have instructed 
employees to change their practice for the period of the study. The simulated client method itself is also prone to 
certain biases especially the ability of the simulated client to appropriately enact the assigned role and to recall details 
of the interaction after the event.    
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Appendices  
 
Table A1: Items used to compute composite scores for indicators of availability of services at facilities 
I. PRE-ABORTION PROCESSES 
1) Pre-procedure counselling 
2) History taking 
3) Medical examination 
4) Pregnancy screening 
II. PAIN MANAGEMENT PROCEDURES 
1) Counselling client 
2) Listening to music 
3) Verbal reassurance 
4) Analgesics 
5) Tranquilizers 
6) Anaesthetics 
III. INFECTION PREVENTION/CONTROL PRACTICES 
1) Hand-washing with soap and water 
2) Wearing protective gear 
3) Routine cleaning of facility  
4) Cleaning/disinfecting medical equipment 
5) Safe disposal of waste 
6) Careful handling and disposal of sharps  
IV. MANAGING ABORTION-RELATED COMPLICATIONS 
1) Vacuum aspiration for uterine evacuation 
2) Dilatation and curettage for uterine evacuation 
3) Misoprostol 
4) Uterotonic drugs 
5) Antibiotics 
6) Blood transfusion 
7) Laparotomy 
8) Prompt referral 
V. DRUGS AND SUPPLIES FOR SURGICAL ABORTION 
1) Clean examination gloves 
2) Heavy duty gloves 
3) Sterile/surgical gloves 
4) Cervical preparation agents 
5) Detergent or soap 
6) Gown/face protection 
7) Needles (22 gauge spinal for para cervical block) 
8) Needles (21 gauge for drug administration) 
9) Syringes (5, 10 and 20ml) 
10) Lidocaine for paracervical block 
11) Gauze sponges or cotton balls 
12) STI/RTI drugs 
13) Antiseptic solution to prepare cervix 
14) Instrument-soaking solution 
15) Sterilization or high-level disinfection solutions 
16) Silicone for lubricating syringes 
VI. DRUGS AND SUPPLIES FOR MEDICAL ABORTION 
1) Misoclear 
2) Cytotec-pharmacia UK 
3) Isovent 
4) Daytech/Dytek 
5) Arthrotec 
6) Mifepristone Linepharma 200mg 
7) Marisg 
8) Mifegyne 
9) Mediprist 
10) Combination of Mifepristone 
and Misoprostol 
VII. RECOVERY, PAIN AND COMPLICATIONS MANAGEMENT 
1) Sanitary napkins/cotton wool 
2) Analgesics 
3) Tranquilizers 
4) Anaesthetics 
5) Uterotonics 
6) Intravenous line and fluids 
VIII. EQUIPMENT FOR SURGICAL/MEDICAL ABORTION 
1) Blood pressure equipment 
2) Stethoscope 
3) Speculum (wide mouth to increase cervix exposure) 
4) Speculum (short to avoid pushing away cervix) 
5) Tenaculum (atraumatic) 
6) Tapered dilators up to 37-51mm or equivalent 
7) Electric vacuum aspirator (14 or 16mm cannulae) 
8) Manual vacuum aspirator and cannulae up to 12mm 
9) Bierer uterine evacuation forceps (large) 
10) Bierer uterine evacuation forceps (small) 
11) Sopher uterine evacuation forceps (small) 
12) Large postpartum flexible curette 
13) Sponge (ring forceps) 
14) Stainless steel bowl for prepping solution 
15) Instrument stray 
16) Clear glass dish for tissue inspection 
17) Long needle-driver and suture 
18) Scissors 
19) Oxygen and Ambu bag 
20) Uterine packing 
21) Strainer (metal, glass or gauze) 
IX. SERVICE STANDARDS AND GUIDELINES 
1) Clear policy on confidentiality of clients 
2) Clear procedures for record-keeping/reporting 
3) Copy of national standards and guidelines 
4) Copy of WHO technical and policy guidance 
5) Clear referral mechanisms to higher level facilities 
X. INFRASTRUCTURE 
1) Private waiting area with seats 
2) Private space for MVA/pelvic exam 
3) Source of clean water for 24 hours 
4) Power for fridge to remain functional 24 hours a day 
5) Working autoclave/sterilization 
6) Reliable lighting 
7) Client toilets 
8) Clean water for drinking 
9) Clean cups/glasses for drinking water 
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Table A2: Items used to compute composite scores for quality of abortion services 
I. HISTORY TAKING 
Provider asked: 
1) Purpose of visit 
2) Client’s age 
3) Client’s marital status 
4) Number of sexual partners 
5) Previous pregnancy history 
6) Previous use of family planning 
7) Client discussed family planning with 
partner 
8) Partner cooperation 
9) History of medical conditions 
10) STIs/HIV risk factors  
11) Unprotected sexual intercourse 
12) Gender-based violence 
13) Allergies 
14) Reasons for wanting to terminate 
pregnancy  
II. MEDICAL EXAMINATION: ORAL 
Provider discussed: 
1) Date of last menstrual period 
2) Whether menstruation was normal 
3) Whether amenorrheic or using injectables 
 
4) Previous history of ectopic pregnancy/STIs 
5) Current use of medications 
6) Experiences of violence or coercion 
III. MEDICAL EXAMINATION: PHYSICAL 
Provider examined/performed: 
1) Pulse 
2) Blood pressure 
3) Temperature 
 
4) Abdomen 
5) Softening cervical isthmus 
6) Softening and enlarging of uterus 
 
7) Presence of STIs/RTIs 
8) Mass pelvic examination 
9) Bimanual examination 
IV. POST-EXAMINATION RECOMMENDATIONS 
1) Pregnancy test 
2) Ultrasound 
3) Rhesus test 
4) HIV counselling/testing 
5) Blood test for haemoglobin only 
6) Blood test for full haemogram 
7) Ectopic pregnancy test 
8) Checking for history of STIs/RTIs 
9) Investigating bleeding tendencies in 
the family 
10) Investigating gender-based 
violence 
V. POST-ABORTION CARE COUNSELLING 
Provider counsels client on: 
1) When to seek further care 
2) Self-care after leaving facility 
 
3) When to resume sexual activity 
4) Prevention of STIs/HIV 
 
5) Family planning 
6) Any other post-abortion aspect 
VI. OVERALL ASSESSMENT OF CONSULTATION 
1) Provider observed infection prevention procedures 
2) Provider informed client about HIV/VCT 
3) Provider conducted HIV/STI risk assessment 
4) Provider counselled client in a supportive way 
5) Provider emphasised importance of dual protection 
6) Provider gave client reminder of when to return 
7) Physical infrastructure ensured client comfort 
8) Physical facilities ensured audio and visual privacy  
VII. CLIENT PERCEPTIONS: HISTORY TAKING/MEDICAL EXAMINATION 
Provider: 
1) Asked about purpose of visit 
2) Asked about medical history 
3) Asked about age 
4) Asked about marital status 
5) Asked about support from partner 
6) Asked about last menstrual period 
7) Asked about duration of pregnancy 
8) Checked blood pressure 
9) Performed abdominal examination 
10) Asked about fertility experiences and intentions 
11) Asked about previous use of family planning 
VIII. CLIENT PERCEPTIONS: CONSULTATION PROCESS 
Provider: 
1) Ensured privacy 
2) Sought consent in a respectful manner 
 
3) Showed non-judgemental attitude 
4) Talked in a language client understood 
IX. CLIENT PERCEPTIONS: INFORMATION GIVEN 
Provider gave information on: 
1) What was going  to be done 
2) What client is likely to experience 
3) How long the process would take 
4) Risks and complications associated with the process 
5) How to manage pain 
6) What to do in case of complications 
7) When client is likely to resume normal activities 
 
8) Other available options for managing the pregnancy 
9) Available psycho-social support services 
10) Child-spacing and family planning 
11) STIs/HIV 
12) Whether and when to return to facility 
13) Written materials on services that client received 
14) Referral to another clinic for more services 
X. CLIENT PERCEPTIONS: SATISFACTION WITH SERVICES 
1) Facility is clean/tidy 
2) Waiting time before seeing provider was reasonable 
3) Provider is always available at the facility 
4) Provider was responsive/understanding 
5) Provider was knowledgeable  
6) Drugs/medicines are always available at facility 
7) Provider treated client with respect 
8) Confidentiality/privacy was ensured 
9) Cost of services was reasonable 
10) Client was happy overall with services at the facility 
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